Results 41 to 50 of about 717,050 (341)

Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial

Trials, 2015
Background It had been reported that up to 37% of the adult male population smokes cigarettes in Qatar. The Global Youth Tobacco Survey also stated that 13.4% of male school students aged 13 to 15 years in Qatar smoke cigarettes. Smoking cessation is key
Maguy Saffouh El Hajj, Nadir Kheir, Ahmad Mohd Al Mulla, Daoud Al-Badriyeh, Ahmad Al Kaddour, Ziyad R Mahfoud, Mohammad Salehi, Nadia Fanous   +7 more
doaj   +1 more source

The association between antitobacco advertising and calls to a tobacco Russian Quitline

Tobacco Induced Diseases, 2018
Background Russian Quitline was organized in 2011, National Tobacco Control mass media campaigns are held with 2012 to 2016, National Tobacco Control Law was passed in 2013.This study examines the effects of media campaign on telephone quitline for ...
Olga Sukhovskaya, Petr Yablonskiy
doaj   +1 more source

Time and age trends in smoking cessation in Europe

PLoS ONE, 2019
Background Smoking is the main risk factor for most of the leading causes of death. Cessation is the single most important step that smokers can take to improve their health.
G. Pesce, A. Marcon, L. Calciano, J. Perret, M. Abramson, R. Bono, J. Bousquet, A. Fois, C. Janson, D. Jarvis, R. Jõgi, B. Leynaert, D. Nowak, V. Schlünssen, Isabel Urrutia-Landa, G. Verlato, S. Villani, T. Zuberbier, C. Minelli, S. Accordini   +19 more
semanticscholar   +1 more source

Medication Use in Multiple Sclerosis: A Population‐Based Comparison With the General Danish Population

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate the overall use of prescription medications among individuals with multiple sclerosis compared to the general population, with a focus on treatments beyond disease‐modifying therapies. Methods We conducted a nationwide, registry‐based study in Denmark.
Josefine Windfeld‐Mathiasen, Henrik Horwitz, Ida M. Heerfordt, Elisabeth Framke, Melinda Magyari   +4 more
wiley   +1 more source

Metabolic Changes Following Smoking Cessation in Patients with Type 2 Diabetes Mellitus

Biomedicines
Background: Smoking cessation is crucial for reducing complications of type 2 diabetes mellitus (T2DM), but associated weight gain can worsen glycemic control, discouraging quitting attempts.
Stamatina Driva, Aliki Korkontzelou, Serena Tonstad, Nikolaos Tentolouris, Eleni Litsiou, Vasiliki Vasileiou, Alice G. Vassiliou, Vassiliki Saltagianni, Paraskevi Katsaounou   +8 more
doaj   +1 more source

IQOS point-of-sale marketing strategies in Israel: a pilot study

Israel Journal of Health Policy Research, 2019
Background Philip Morris International’s IQOS (“I Quit Ordinary Smoking”) device has increasingly penetrated the global tobacco market. In Israel, among the first countries with IQOS in its market, the IQOS device is sold in specialty stores and online ...
Yael Bar-Zeev, Hagai Levine, Gil Rubinstein, Ihab Khateb, Carla J. Berg   +4 more
doaj   +1 more source

Change in Cognition Following Ischaemic Stroke

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive decline can occur following ischaemic stroke. How cognition changes over time and associations with cognitive change are poorly understood. This study aimed to explore these issues over 2 years following ischaemic stroke.
Wenci Yan, Terence Quinn, Alex McConnachie, Niall Broomfield, Yun Wong, David Dickie, Kirsten Forbes, Matthew Walters, Jesse Dawson   +8 more
wiley   +1 more source

Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study

Monaldi Archives for Chest Disease, 2017
A large number of COPD patients are smokers. The particular characteristics of this group as well as their need to quit usually require psychological counselling and pharmacological treatment to achieve abstinence and, often, intensively.
Carlos A. Jiménez-Ruiz, Marcos Garcia Rueda, Manuel A. Martinez Muñiz, Jacobo Sellarés, Maria A. Jiménez-Fuentes, Lourdes Lázaro Asegurado, Esther Rodríguez Gonzalez, Concepción Rodriguez Garcia, Oriol Armengol, Emilia Abad, Teresa Peña, Adolfo Domenech del Rio, Juan A. Riesco Miranda   +12 more
doaj   +1 more source

Hypnotherapy for smoking cessation.

Cochrane Database of Systematic Reviews, 2019
BACKGROUND Hypnotherapy is widely promoted as a method for aiding smoking cessation. It is intended to act on underlying impulses to weaken the desire to smoke, or strengthen the will to stop.
Joanne Barnes, H. McRobbie, C. Dong, Natalie Walker, J. Hartmann-Boyce   +4 more
semanticscholar   +1 more source

Antidepressants for smoking cessation

Cochrane Database of Systematic Reviews, 2023
The pharmacological profiles and mechanisms of antidepressants are varied. However, there are common reasons why they might help people to stop smoking tobacco: nicotine withdrawal can produce short-term low mood that antidepressants may relieve; and some antidepressants may have a specific effect on neural pathways or receptors that underlie nicotine ...
Hajizadeh, A, Howes, S, Theodoulou, A, Klemperer, E, Hartmann-Boyce, J, Livingstone-Banks, J, Lindson, N   +6 more
openaire   +3 more sources